In Utero Gene Therapy and Genome Editing

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Current Stem Cell Reports

• Publication date

  2018-03-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s40778-018-0117-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Inducing indel mutation in the SOX6 gene by zinc finger nuclease for gamma reactivation: An approach towards gene therapy of beta thalassemia

  2018cited by this paper
• Delivery technologies for genome editing

  2017cited by this paper
• Correction of a pathogenic gene mutation in human embryos

  2017cited by this paper
• Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward.

  2017cited by this paper
• Induction of Immune Tolerance to Foreign Protein via Adeno-Associated Viral Vector Gene Transfer in Mid-Gestation Fetal Sheep

  2017cited by this paper
• Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism

  2017cited by this paper
• Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5ch and AAV1.

  2017cited by this paper
• Placenta-directed gene therapy for fetal growth restriction.

  2017cited by this paper
• Fetal stem cell and gene therapy.

  2017cited by this paper
• In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model

  2017cited by this paper
• Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early‐onset fetal growth restriction

  2016cited by this paper
• In vivo gene editing in dystrophic mouse muscle and muscle stem cells

  2016cited by this paper
• In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy

  2016cited by this paper
• A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice

  2016cited by this paper
• Gene therapy for hemophilia: past, present and future.

  2016cited by this paper
• Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia

  2016cited by this paper
• Peri- and Postnatal Effects of Prenatal Adenoviral VEGF Gene Therapy in Growth-Restricted Sheep1

  2016cited by this paper
• Genome-editing Technologies for Gene and Cell Therapy

  2016cited by this paper
• Homology-driven genome editing in hematopoietic stem and progenitor cells using zinc finger nuclease mRNA and AAV6 donors

  2015cited by this paper
• Intraplacental Gene Therapy with Ad-IGF-1 Corrects Naturally Occurring Rabbit Model of Intrauterine Growth Restriction

  2015cited by this paper
• Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses

  2015cited by this paper
• Gene therapy returns to centre stage

  2015cited by this paper
• Adeno-associated virus serotypes for gene therapeutics.

  2015cited by this paper
• Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype

  2014cited by this paper
• Uteroplacental Adenovirus Vascular Endothelial Growth Factor Gene Therapy Increases Fetal Growth Velocity in Growth-Restricted Sheep Pregnancies

  2014cited by this paper
• Developmental stage determines efficiency of gene transfer to muscle satellite cells by in utero delivery of adeno-associated virus vector serotype 2/9

  2014cited by this paper
• Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery

  2014cited by this paper
• In Utero Lung Gene Transfer Using Adeno-Associated Viral and Lentiviral Vectors in Mice

  2014cited by this paper
• Efficient Delivery of Genome-Editing Proteins In Vitro and In Vivo

  2014cited by this paper
• RNA-programmed genome editing in human cells

  2013cited by this paper
• Multiplex Genome Engineering Using CRISPR/Cas Systems

  2013cited by this paper
• Self-Reactive CFTR T Cells in Humans: Implications for Gene Therapy

  2013cited by this paper
• Correction of a genetic disease in mouse via use of CRISPR-Cas9.

  2013cited by this paper
• RNA-Guided Human Genome Engineering via Cas9

  2013cited by this paper
• Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ.

  2013cited by this paper
• Successful Gene Therapy in Utero for Lethal Murine Hypophosphatasia

  2012cited by this paper
• A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

  2012cited by this paper
• Early intra-amniotic gene transfer using lentiviral vector improves skin blistering phenotype in a murine model of Herlitz junctional epidermolysis bullosa

  2011cited by this paper
• Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease

  2011cited by this paper
• Fetal muscle gene therapy/gene delivery in large animals.

  2011cited by this paper
• Adeno-Associated Virus Antibody Profiles in Newborns, Children, and Adolescents

  2011cited by this paper
• Adenoviral vector immunity: its implications and circumvention strategies.

  2011cited by this paper
• Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques.

  2011cited by this paper
• Defining fetal growth restriction in mice: A standardized and clinically relevant approach.

  2011cited by this paper
• Nonhomologous DNA end joining (NHEJ) and chromosomal translocations in humans.

  2010cited by this paper
• The developmental stage determines the distribution and duration of gene expression after early intra-amniotic gene transfer using lentiviral vectors

  2010cited by this paper
• Regulation of homologous recombination in eukaryotes.

  2010cited by this paper
• Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease

  2009cited by this paper
• Factors Determining the Risk of Inadvertent Retroviral Transduction of Male Germ Cells After In Utero Gene Transfer in Sheep

  2008cited by this paper
• CRISPR — a widespread system that provides acquired resistance against phages in bacteria and archaea

  2008cited by this paper
• Early fetal gene delivery utilizes both central and peripheral mechanisms of tolerance induction.

  2008cited by this paper
• Full-length dystrophin gene transfer to the mdx mouse in utero

  2008cited by this paper
• Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection.

  2008cited by this paper
• Persistent expression of hF.IX After tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice.

  2007cited by this paper
• Engineered I-CreI derivatives cleaving sequences from the human XPC gene can induce highly efficient gene correction in mammalian cells.

  2007cited by this paper
• CD8+ T-cell responses to adeno-associated virus capsid in humans

  2007cited by this paper
• Fetal gene therapy of α-thalassemia in a mouse model

  2007cited by this paper
• Homing endonuclease I-CreI derivatives with novel DNA target specificities

  2006cited by this paper
• Male germ-line cells are at risk following direct-injection retroviral-mediated gene transfer in utero.

  2005cited by this paper
• Widespread and highly persistent gene transfer to the CNS by retrovirus vector in utero: implication for gene therapy to Krabbe disease

  2005cited by this paper
• In utero gene therapy rescues vision in a murine model of congenital blindness.

  2004cited by this paper
• Performance of high-throughput DNA quantification methods

  2003cited by this paper
• Ultrasound-Guided Percutaneous Delivery of Adenoviral Vectors Encoding the β-Galactosidase and Human Factor IX Genes to Early Gestation Fetal Sheep In Utero

  2003cited by this paper
• In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor.

  2003cited by this paper
• Transfection by Electroporation

  2003cited by this paper
• In Utero Injection of α-L-Iduronidase-Carrying Retrovirus in Canine Mucopolysaccharidosis Type I: Infection of Multiple Tissues and Neonatal Gene Expression

  2002cited by this paper
• Induction of stable prenatal tolerance to beta-galactosidase by in utero gene transfer into preimmune sheep fetuses.

  2001cited by this paper
• The spfash mouse: a missense mutation in the ornithine transcarbamylase gene also causes aberrant mRNA splicing.

  1989cited by this paper
• THE ACQUIRED IMMUNITY CONCEPT IN KIDNEY HOMOTRANSPLANTATION

  1955cited by this paper
• ‘Actively Acquired Tolerance’ of Foreign Cells

  1953cited by this paper
• IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS.

  1945cited by this paper

• Advancing precision care in pregnancy through a treatable fetal findings list.

  2025cites this paper
• In utero gene therapy: Pioneering diagnostic and therapeutic technologies

  2025cites this paper
• InUtero Gene Therapy: Progress and Challenges.

  2021cites this paper
• Delivery technologies for in utero gene therapy.

  2020cites this paper
• In Utero Gene Therapy (IUGT) Using GLOBE Lentiviral Vector Phenotypically Corrects the Heterozygous Humanised Mouse Model and Its Progress Can Be Monitored Using MRI Techniques

  2019cites this paper
• Treatment of heritable diseases using CRISPR: Hopes, fears, and reality.

  2018cites this paper